ACET — ADICET BIO INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ACET?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their ACET position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +1 tracked investor added or increased positions last quarter (Ken Griffin)
- +1 tracked investors reported holding ACET at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About ADICET BIO INC (ACET)
ADICET BIO INC (ACET) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $10M. Across recent filings, tracked investors recorded 3 new positions, 2 increased, 7 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ACET
How many top investors track ACET
Only 1 tracked investor report this position.
ACET Ownership Composition
How ADICET BIO INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ACET
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares466.2KValue$4M% Portfolio0.00%
Previously held ACET
These investors reported ACET in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Izzy Englander | Millennium Management | 566K | $458.5K | Sep 30, 2025 |
Recent activity
- Reduced$2.8M(-45.92%)Nov 14, 2024
- Reduced$1.7M(-7.37%)Feb 14, 2025
- Reduced$924K(-32.54%)May 15, 2025
- Reduced$361.3K(-51.60%)Aug 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- Reduced$77.8K(-89.79%)Nov 14, 2024
- New$983.1KMay 15, 2025
- Reduced$297.4K(-62.55%)Aug 14, 2025
- Increased$473.1K(19.76%)Nov 14, 2025
- Reduced$907.8K(-81.54%)Feb 17, 2026
- Increased$4M(22.11%)Aug 14, 2026
- New$640.3KAug 14, 2024
- $9.6MMay 15, 2024
Frequently asked questions
- How many institutional investors hold ACET?
- 1 tracked institutional investor disclosed a position in ACET (ADICET BIO INC) in their most recent 13F filing.
- Who is the largest institutional holder of ACET?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ACET, valued at $10M.
- Did institutional ownership of ACET increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 2 increased, 7 reduced, and 1 fully exited ACET.
- Where does this ACET ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.